Evidence map›Paper›PMID 31131283›Full record

ReviewFrontiers in molecular biosciences2019

Melting Down Protein Stability: PAPS Synthase 2 in Patients and in a Cellular Environment.

Oliver Brylski, Simon Ebbinghaus, Jonathan W Mueller

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Editorial: Sulfation Pathways-There and Back Again.Frontiers in molecular biosciences · 2022
    Article
  3. Article
  4. Sulfation pathways from red to green.The Journal of biological chemistry · 2019
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Oliver BrylskiInstitute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Braunschweig, Germany.
Simon EbbinghausInstitute of Physical and Theoretical Chemistry, Technische Universität Braunschweig, Braunschweig, Germany.
Jonathan W MuellerInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Technische Universität Braunschweig · DEUniversity of Birmingham · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Within the crowded and complex environment of the cell, a protein experiences stabilizing excluded-volume effects and destabilizing quinary interactions with other proteins. Which of these prevail, needs to be determined on a case-by-case basis. PAPS synthases are dimeric and bifunctional enzymes, providing activated sulfate in the form of 3'-phosphoadenosine-5'-phosphosulfate (PAPS) for sulfation reactions. The human PAPS synthases PAPSS1 and PAPSS2 differ significantly in their protein stability as PAPSS2 is a naturally fragile protein. PAPS synthases bind a series of nucleotide ligands and some of them markedly stabilize these proteins. PAPS synthases are of biomedical relevance as destabilizing point mutations give rise to several pathologies. Genetic defects in PAPSS2 have been linked to bone and cartilage malformations as well as a steroid sulfation defect. All this makes PAPS synthases ideal to study protein unfolding, ligand binding, and the stabilizing and destabilizing factors in their cellular environment. This review provides an overview on current concepts of protein folding and stability and links this with our current understanding of the different disease mechanisms of PAPSS2-related pathologies with perspectives for future research and application.

Indexed as

enzyme storage complexexcluded volume effectligand stabilizationPAPS synthasequinary interactionsulfation pathways

Identifiers

PMID31131283
PMCPMC6509946
OpenAlexW2943491666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.